New Products

• E325125

  EIDD-2801

  COVID-19 research

  ≥98%
• E5578

  Entecavir Hydrate

  Nucleoside (deoxyguanosine) analog; DNA chain t...

  ≥99%
• E622698

  Eprosartan Mesylate

  Nonpeptide angiotensin II receptor antagonist

  ≥99%
• E846182

  Everolimus EP Impurity E

  Impurity of everolimus

  ≥90%
• F130280

  FHD-286

  BRG1/BRM ATPase inhibitor

  ≥98%
• F285081

  Fidaxomicin

  Macrocycle

  ≥98%
• G124086

  GDC-0152 Free Base

  Promotes degradation of cIAP1

  ≥96%
• G124088

  GDC-1971

  SHP2 inhibitor

  ≥99%
• G124090

  GDC-6036

  KRAS inhibitor

  ≥98%
• G823720

  Gusacitinib

  SYK/JAK inhibitor

  ≥98%
• H000051

  H-151

  STING antagonist

  ≥99%
• H9803

  Hyaluronic Acid Sodium (0.2 -5 kDA)

  Glycosaminoglycan
• H9802

  Hyaluronic Acid Sodium (7-10 kDA)

  Glycosaminoglycan
• H978583

  Hyoscyamine sulfate dihydrate

  ≥99%
• I5206

  INCB 28060 Hydrochloride Hydrate

  c-MET inhibitor.

  ≥98%
• I527211

  Infigratinib Phosphate

  FGFR inhibitor.

  ≥98%
• K040007

  KB-0742

  CDK9 inhibitor.

  ≥98%
• K040009

  KB-0742 dihydrochloride

  CDK9 inhibitor.

  ≥99%
• L283080

  LHC-165

  TLR7 agonist

  ≥99%
• L283720

  Losartan Carboxylic acid

  Active metabolite of losartan

  ≥ 99%
• L8261

  Lupeol

  Triterpene; potential tyrosinase inhibitor.

  ≥98%
• L930280

  LXH254

  pan-RAF inhibitor

  ≥99%
• L960012

  LY-3214996

  ERK1/2 inhibitor.

  ≥98%
• L961000

  LY-3295668

  Aurora kinase A inhibitor

  ≥99%
• M177521

  Menaquinone-7

  2-methyl-1,4-naphthoquinone derivative

  98%

Showing 51–75 of 117 results